LINC02869: A Potential Drug Target for Fibrosis and Inflammation

Target Name: LINC02869

NCBI ID: G440714

LINC02869

Other Name(s): C1orf143 | long intergenic non-protein coding RNA 2869 | Long intergenic non-protein coding RNA 2869

LINC02869: A Potential Drug Target for Fibrosis and Inflammation

LINC02869 (C1orf143) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the C1rpo gene family, which is known for its role in the regulation of cytokinesis and cell signaling. LINC02869 has been shown to play a role in the regulation of inflammation and fibrosis, and is Therefore, it is a potential drug target or biomarker.

The C1rpo gene family is a member of the superfamily of cytoskeletal proteins known as the coiled-coil proteins. These proteins are characterized by the presence of a coiled-coil region, which is a regions of the protein that can form a helical structure when the protein is unfolded. C1rpo proteins have been shown to play a role in the regulation of cytokinesis, cell signaling, and inflammation.

LINC02869 is a 21-kDa protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the C1rpo gene family and is characterized by the presence of a 21-kDa protein that is formed by the fusion of two alpha-helices. LINC02869 is expressed in a variety of tissues and has been shown to play a role in the regulation of inflammation and fibrosis.

One of the key functions of LINC02869 is its role in the regulation of cytokinesis. Cytokinesis is the process by which eukaryotic cells produce new cells, and it is regulated by a variety of factors, including cytokines. LINC02869 has been shown to play a role in the regulation of cytokinesis by activating the cytoskeleton and preventing the degradation of new cytoskeletal components.

In addition to its role in cytokinesis, LINC02869 is also involved in the regulation of cell signaling. It has been shown to play a role in the regulation of cell adhesion, cell migration, and the regulation of ion channels. LINC02869 may also be involved in the regulation of cell signaling by interacting with signaling molecules such as TGF-β and NF-kappa-B.

Finally, LINC02869 is also involved in the regulation of inflammation and fibrosis. Fibrosis is a process by which tissues become fibrotic and are no longer functional. LINC02869 has been shown to play a role in the regulation of fibrosis by preventing the activation and recruitment of fibroblasts, which are cells that are involved in the production of extracellular matrix (ECM) components.

In conclusion, LINC02869 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of cytokinesis, cell signaling, and inflammation. It may be a potential drug target or biomarker for the treatment of a variety of diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 2869

The "LINC02869 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02869 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets